was a nine year study designed to test whether persistently high blood sugar levels are related to the development of complications in people with type 1 diabetes. The results demonstrated that intensive treatment of individuals with type 1 diabetes can delay the onset and progression of long-term complications in people.
The DCCT was a 10-year study of more than 1,400 people with type 1 diabetes sponsored by the National Institutes of Health. It showed what many diabetes specialists had suspected for years, that tight blood-glucose control significantly reduces risk of all diabetic complications: cardiovascular disease, eye disease (retinopathy), kidney disease (nephropathy), and nerve damage (neuropathy).
DCCT A 10-year study (1983-1993) funded by the National Institute of Diabetes and Digestive and Kidney Diseases to assess the effects of intensive therapy on the long-term complications of diabetes. The study proved that intensive management of insulin-dependent diabetes prevents or slows the development of eye, kidney, and nerve damage caused by diabetes.
A 10-year study that compared the health of patients with type 1 diabetes receiving two different levels of treatment. Patients who maintained near normal blood sugar control through more intensive management had far less risk of developing eye, kidney, and nerve damage.
A 10-year study reported in 1993 of more than 1,400 people with type 1 diabetes that was sponsored by the National Institutes of Health. It showed that improved blood glucose control significantly reduces the risk of diabetic retinopathy, neuropathy, and nephropathy. However, it also demonstrated that this improved control comes with an increase in weight and incidence of hypoglycemia.
a study by the National Institute of Diabetes and Digestive and Kidney Diseases, conducted from 1983 to 1993 in people with type 1 diabetes. The study showed that intensive therapy compared to conventional therapy significantly helped prevent or delay diabetes complications. Intensive therapy included multiple daily insulin injections or the use of an insulin pump with multiple blood glucose readings each day. Complications followed in the study included diabetic retinopathy, neuropathy, and nephropathy.
This study of 1,441 type 1 patients with diabetes over a period of nine years was completed and reported in September 1993. It conclusively demonstrated that glycemic control is a major deterrent to the development and progression of diabetic microvascular and neuropathic disease.
The Diabetes Control and Complications Trial, or DCCT was the largest, most comprehensive diabetes study ever conducted at the time.
